Rituximab: clinical development and future directions

By Cheson Bruce D  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 1, 2002-01 ,pp. : 97-110

Informa Healthcare

Access to resources Recommend Favorite

Biosimilars: current status and future directions

By Roger Simon D  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 7, 2010-07 ,pp. : 1011-1018

Informa Healthcare

Access to resources Recommend Favorite

Functional analysis of ABCA8, a new drug transporter

By Tsuruoka S.   Ishibashi K.   Yamamoto H.   Wakaumi M.   Suzuki M.   Schwartz G.J.   Imai M.   Fujimura A.  

Biochemical and Biophysical Research Communications, Vol. 298, Iss. 1, 2002-10 ,pp. : 41-45

Elsevier

Access to resources Recommend Favorite

Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers

By Akamine Yumiko   Miura Masatomo   Sunagawa Satoko   Kagaya Hideaki   Yasui-Furukori Norio   Uno Tsukasa  

Xenobiotica, Vol. 40, Iss. 11, 2010-11 ,pp. : 782-789

Informa Healthcare

Access to resources Recommend Favorite

A regulatory viewpoint on transporter-based drug interactions

By Zhang L.   Zhang Y.   Strong J. M.   Reynolds K. S.   Huang S. -M.  

Xenobiotica, Vol. 38, Iss. 7-8, 2008-07 ,pp. : 709-724

Informa Healthcare

Access to resources Recommend Favorite